Latest News

Senseonics touts patient access program for Eversense CGM

SenseonicsSenseonics¬†(NYSE:SENS) said today that it launched the Eversense Bridge Program, which is designed to improve patient access to Senseonics’ Eversense continuous glucose monitoring system.

The company said that the program can help users confirm their insurance benefits and obtain pre-authorization before sensor placement. The Eversense Bridge Program is also meant to help healthcare providers and patients appeal to insurers regarding denied claims.

Get the full story at our sister site, Drug Delivery Business News.

The post Senseonics touts patient access program for Eversense CGM appeared first on MassDevice.

Source link

Related posts

Magnetoresistance in an electronic cavity coupled to one-dimensional systems


Clinical trial assesses telephone-based care program for at-risk homebound elderly


Biomarkers can predict treatment response in women with endometriosis


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World